— Ozempic & GLP-1 drugs · stomach and vision claims
🔒 Encrypted & handled per our Privacy Policy

Stomach injury claims
in MDL 3094, July 2026
Vision loss claims
in the newer MDL 3163
Key expert hearing
set for 2026
✓
Or you had a bowel obstruction or ileus
Your intestines stopped moving properly. Many of these cases involved emergency admission and sometimes surgery.
Ordinary nausea is not a claim, and firms will tell you so. But repeated vomiting that puts you in hospital, or vision that never came back, is a different matter. A free review sorts it out in about two minutes.
— Educational
These drugs control blood sugar for millions of people with type 2 diabetes. Stopping suddenly can be dangerous. They also work well for a great many people who have no problems at all.
Nothing on this page is medical advice, and nothing here is a reason to skip a dose. If this page worries you, call your prescribing doctor and ask. That is a decision between you and your physician. It is completely separate from any legal question, and talking to a lawyer never changes your treatment.
GLP-1 receptor agonists copy a hormone your gut releases after eating. They tell your brain you are full and they slow down how fast your stomach empties. That slowing is not a side effect. It is how the drugs work.
The lawsuits are about what happens when the slowing does not stop.In some people the stomach nearly quits emptying altogether. That is gastroparesis, or stomach paralysis. Food sits for hours or days. It brings relentless nausea, vomiting of food eaten long before, bloating and severe pain. For some it eases after stopping the drug. For others it does not.asbestos. That is unusual.
A second set of claims involves the intestines stopping — ileus or bowel obstruction — which is a medical emergency and sometimes needs surgery.
The core allegation in all of it is failure to warn: that Novo Nordisk and Eli Lilly knew or should have known how severe this could get, and did not say so clearly enough on the label.
Gastroparesis, ileus and intestinal obstruction. 3,848 cases pending as of July 2026 in the Eastern District of Pennsylvania before Judge Karen S. Marston.
Court materials cover Ozempic, Wegovy, Rybelsus, Victoza and Saxenda from Novo Nordisk, and Trulicity, Mounjaro and Zepbound from Eli Lilly.
NAION, a sudden loss of blood flow to the optic nerve that usually causes permanent sight loss in one eye. Created in December 2025 with 21 cases, now around 150.
A 2024 study reported semaglutide users were roughly four times more likely to develop NAION than a comparison group. A parallel case is also proceeding in New Jersey state court.
The court has set a Rule 702 hearing on expert testimony for September 2026, covering warnings, federal preemption and causation. It is not a trial. It decides which scientific experts are allowed to testify at all. The rulings that follow will largely determine whether this litigation heads toward trials or narrows sharply. Anyone weighing a claim should understand that this — not a settlement — is the next real event.
In May 2026 the court allowed key expert testimony on gastroparesis and other gastrointestinal injuries to proceed, keeping that evidence alive. Case filings kept climbing afterward, adding more than 100 in a single month. Separately, the FDA has sent Novo Nordisk a warning letter over its reporting of side effects. None of that is a verdict, and none of it is a settlement.
Neither MDL has produced a verdict and there is no settlement in either one. No fund, no payment schedule, nothing approved by any court. Any dollar range you find quoted online for Ozempic claims is invention. The defendants dispute causation entirely, and these are unproven allegations — no court has found either manufacturer liable.
If you are on a GLP-1 drug and you have persistent vomiting, cannot keep food down, have severe stomach pain, have stopped passing stool or gas, or notice a sudden change in your vision, contact your doctor right away. A bowel obstruction and sudden vision loss are both emergencies. Do not stop or change any medication based on what you read here.
— Compensation
If a claim succeeds, compensation is meant to cover what the injury has cost you — in money, in work, and in daily life. Here is what these claims typically seek.
— The process
You do not need pharmacy records or exact dates to start. Tell us what you remember and the firm does the rest.
Fill out the short form or call. Which drug, roughly when you started, and what you were diagnosed with. It takes about two minutes. There is no cost and no obligation.
If your situation fits, we connect you with a participating law firm. That firm decides on its own whether to represent you, and which of the two litigations your claim belongs in. If it takes the case, you sign directly with the firm.
Pharmacy records showing what you were dispensed and when, plus hospital records, gastric emptying studies or eye exams. In these cases the timeline is the case.
Your case is filed and coordinated in the appropriate MDL or state court. Your firm keeps you updated through the expert rulings ahead. You are never required to accept an offer you do not want.
— WHY PEOPLE TRUST US
💰
The review is free. Participating firms work on contingency, so a fee is owed only out of a recovery. No recovery, no attorney fee.
⚖️
Stomach claims and vision claims are separate cases with different experts. We connect you with firms working in the right one.
Pharmacy and hospital records hold the dates these cases turn on. A firm can request them for you.
Your information is encrypted and handled according to our Privacy Policy. You are never obligated to move forward.
What Direct2Attorney is
A legal marketing and referral service. We check whether your situation matches what participating law firms are looking for, and connect you with one of them if it does.
What Direct2Attorney is not
We are not a law firm. We cannot give you legal advice, represent you, or file anything on your behalf. Only a law firm you sign with can do that.
If you took Ozempic, Wegovy, Mounjaro or another GLP-1 drug and were diagnosed with stomach paralysis, a bowel obstruction or sudden vision loss, find out where you stand. It takes about two minutes and costs nothing. Your state’s filing deadline is running either way — and asking a lawyer never changes your medical treatment.
Participating law firms are generally reviewing two kinds of claims. First, people who took a GLP-1 drug and were diagnosed with gastroparesis, also called stomach paralysis, or with ileus or a bowel obstruction. Second, people who suffered sudden vision loss diagnosed as NAION. In both groups the diagnosis normally needs to come after starting the drug and be documented in medical records. Families may bring a claim for a loved one who died.
Do not stop on your own. These drugs control blood sugar for millions of people with type 2 diabetes, and stopping suddenly can be dangerous. Nothing on this page is medical advice and nothing here is a reason to skip a dose. If this page worries you, call your prescribing doctor and ask. That is a medical decision between you and your physician, and it is completely separate from any legal question.
Gastroparesis means the stomach empties far too slowly, or stops emptying properly at all. Food sits inside for hours or days. It causes severe nausea, repeated vomiting sometimes of food eaten long before, bloating, pain and unintended weight loss. It is diagnosed with a gastric emptying study. For some people it improves after stopping the drug, and for others it does not.
Yes. The litigation covers the whole GLP-1 class, not just Ozempic. Court materials identify Ozempic, Wegovy, Rybelsus, Victoza and Saxenda from Novo Nordisk, and Trulicity, Mounjaro and Zepbound from Eli Lilly. The name on your pen does not decide whether you have a claim.
The court has set a Rule 702 hearing on expert testimony, covering warnings, federal preemption and causation. It is not a trial. It decides which scientific experts may testify. Rulings expected after it will largely determine whether this litigation moves toward trials or narrows sharply. Anyone considering a claim should understand that this is the pivotal moment, not a settlement.
Nothing to ask. The case review is free with no obligation. If a participating law firm takes your case, it will normally work on contingency. That means the fee comes out of a recovery, and no fee is owed if there is no recovery.
No. Direct2Attorney is a legal marketing and referral service, not a law firm. An attorney-client relationship may form only after a participating law firm reviews your information and signs a separate representation agreement with you.
Ask it on the call. The review is free, and there is no obligation to move forward.